Lancet Global Health

Papers
(The H4-Index of Lancet Global Health is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Correction to Lancet Glob Health 2021; 9: e1679–871095
Indonesia's first nationwide health screening programme456
The cause of nodding syndrome remains unknown425
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6378
Resolving the CD4-testing crisis to help end AIDS-related deaths355
Mpox vaccination strategies in DR Congo354
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study323
C-reactive protein: another addition to our armamentarium against tuberculosis?315
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study313
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications289
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study285
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou266
The drug drought in maternal health: an ongoing predicament213
Is now the time for revisiting supplements for pregnant women?209
The road to malaria elimination: why a robust surveillance system is imperative195
Expanding access to long-acting HIV therapy in low-income and middle-income countries188
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial179
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis178
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply175
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)173
The future of the International Health Regulations172
Influenza vaccination in failing hearts166
Bringing home manufacturing of medical products163
Preventing pellagra during isoniazid preventive treatment161
Racism and health: the need for urgent action160
Global health research funding applications: brain drain under another name?155
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m153
Challenges in operationalising clinical trials in India during the COVID-19 pandemic151
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial150
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study142
Outcomes of rheumatic fever in Uganda: a prospective cohort study138
The health status of Indonesia's provinces: the double burden of diseases and inequality gap136
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr135
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis130
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study117
Global patterns and trends in Kaposi sarcoma incidence: a population-based study116
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study115
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study112
The pneumonia challenge: time to end the global neglect111
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor111
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis108
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys108
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019100
Payment in arrears: a global health inequity that must be corrected99
Improving access to liposomal amphotericin B worldwide98
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine98
Lessons for future implementation of the E-MOTIVE bundle97
Experiences of an Israeli hospital in the management of repatriated civilian hostages97
Correction to Lancet Glob Health 2023; 11: e1978–8595
The social determinants of tuberculosis in the Philippines94
Bridging the gap between science and policy in global health governance94
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study94
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned91
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer90
Using verbal autopsy to enhance mortality surveillance90
Using theory to understand how interventions work and inform future implementation88
Correction to Lancet Glob Health 2015; 3: e19688
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns87
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study87
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry85
Routine immunisation coverage in the context of seasonal influenza vaccine introduction for children in Nakuru and Mombasa counties in Kenya, 2019–21: an observational study85
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all84
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:83
Pregnancy in people who have survived Ebola virus disease83
Mpox: evidence for strengthening and sustaining global surveillance82
How to DREAMM and end HIV-related deaths82
Commitment and innovation on the road to people-centred PHC financing80
Addressing the complex needs of people with severe mental health disorders in low-resource settings80
Addressing the social inequities of vaccination: an imperative to close the gap78
Highlighting the need for investment and innovation in ART retention interventions75
Cervical cancer elimination: actions needed in the COVID-19 era75
Correction to Lancet Glob Health 2022; 10: e1443–5274
Staying focused on protecting young people from the harms of tobacco smoke74
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply73
0.039840936660767